X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3825) 3825
Newsletter (222) 222
Newspaper Article (74) 74
Magazine Article (25) 25
Dissertation (13) 13
Book Chapter (9) 9
Publication (5) 5
Streaming Video (2) 2
Transcript (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
liraglutide (3570) 3570
humans (1869) 1869
type 2 diabetes (1396) 1396
endocrinology & metabolism (1328) 1328
diabetes mellitus, type 2 - drug therapy (1208) 1208
diabetes (1175) 1175
male (1128) 1128
hypoglycemic agents - therapeutic use (949) 949
glucagon-like peptide-1 (926) 926
female (858) 858
glucagon-like peptide 1 - analogs & derivatives (759) 759
exenatide (724) 724
glucagon (720) 720
obesity (709) 709
animals (696) 696
insulin (692) 692
middle aged (678) 678
glucose (655) 655
diabetes mellitus (577) 577
metformin (542) 542
glp-1 (537) 537
research (519) 519
pharmacology & pharmacy (503) 503
glucagon-like peptide 1 - therapeutic use (480) 480
glycemic control (476) 476
liraglutide - therapeutic use (468) 468
treatment outcome (468) 468
analysis (460) 460
aged (453) 453
drug therapy (443) 443
safety (441) 441
adult (424) 424
peptides (415) 415
diabetes therapy (412) 412
hypoglycemic agents - administration & dosage (401) 401
care and treatment (396) 396
clinical trials (393) 393
diabetes mellitus, type 2 - blood (387) 387
hypoglycemic agents - adverse effects (380) 380
efficacy (377) 377
hypoglycemic agents - pharmacology (363) 363
body weight (341) 341
risk factors (340) 340
open-label (333) 333
double-blind (329) 329
medicine, general & internal (325) 325
mice (321) 321
glucagon-like peptide-1 receptor - agonists (318) 318
blood glucose - drug effects (309) 309
glucagon-like peptide 1 (305) 305
liraglutide - pharmacology (302) 302
internal medicine (297) 297
blood glucose - metabolism (285) 285
hypoglycemia (278) 278
medical research (274) 274
hypoglycemic agents (270) 270
glucagon-like peptide 1 - pharmacology (268) 268
health aspects (262) 262
sitagliptin (261) 261
peptides - therapeutic use (258) 258
glucagon-like peptide-1 receptor (257) 257
type 2 diabetes mellitus (257) 257
cardiovascular outcomes (256) 256
rats (254) 254
insulin resistance (249) 249
weight loss (242) 242
dextrose (241) 241
diabetes mellitus, type 2 - complications (240) 240
medicine & public health (236) 236
medicine, experimental (235) 235
hyperglycemia (231) 231
dosage and administration (227) 227
abridged index medicus (225) 225
body mass index (224) 224
liraglutide - administration & dosage (224) 224
drug therapy, combination (223) 223
obesity - drug therapy (222) 222
venoms - therapeutic use (222) 222
diabetes mellitus, type 2 - metabolism (218) 218
double-blind method (217) 217
medicine, research & experimental (217) 217
patients (216) 216
risk (215) 215
type-2 (212) 212
glucagon-like peptide 1 - administration & dosage (199) 199
endocrinology (198) 198
mortality (195) 195
glycated hemoglobin a - metabolism (194) 194
beta-cell function (192) 192
weight loss - drug effects (192) 192
metabolism (186) 186
glycosylated hemoglobin (185) 185
receptors, glucagon - agonists (184) 184
cardiovascular diseases (181) 181
management (181) 181
type-2 diabetes-mellitus (180) 180
physiological aspects (179) 179
glucagon-like peptide 1 - adverse effects (178) 178
therapy (177) 177
body weight - drug effects (176) 176
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3958) 3958
German (86) 86
French (33) 33
Spanish (30) 30
Chinese (23) 23
Japanese (21) 21
Russian (18) 18
Czech (14) 14
Italian (14) 14
Portuguese (11) 11
Danish (7) 7
Hungarian (6) 6
Korean (4) 4
Persian (2) 2
Polish (2) 2
Slovak (2) 2
Arabic (1) 1
Croatian (1) 1
Dutch (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 9, pp. 839 - 848
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 4, pp. 311 - 322
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 7, pp. 637 - 646
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 06/2015, Volume 46, Issue 4, pp. 877 - 888
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2017, Volume 19, Issue 5, pp. 672 - 681
Aims To characterize gastrointestinal adverse events (AEs) with different glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs). Methods Two retrospective... 
liraglutide | gastrointestinal disorders | type 2 diabetes | adverse events | GLP‐1 receptor agonists | exenatide | GLP-1 receptor agonists | GLYCEMIC CONTROL | EXENATIDE TWICE | SAFETY | ONCE-DAILY LIRAGLUTIDE | SYMPTOMS | RANDOMIZED CONTROLLED-TRIAL | DIABETES-MELLITUS | NON-INFERIORITY | ENDOCRINOLOGY & METABOLISM | OPEN-LABEL TRIAL | TYPE-2 | Glycated Hemoglobin A - analysis | Gastrointestinal Diseases - physiopathology | Nausea - chemically induced | Gastrointestinal Diseases - epidemiology | Humans | Male | Nausea - physiopathology | Patient Dropouts | Weight Loss - drug effects | Exenatide | Nausea - epidemiology | Peptides - administration & dosage | Incidence | Hypoglycemia - prevention & control | Glucagon-Like Peptide-1 Receptor - metabolism | Venoms - administration & dosage | Female | Retrospective Studies | Severity of Illness Index | Hyperglycemia - prevention & control | Drug Administration Schedule | Venoms - adverse effects | Self Report | Diabetes Mellitus, Type 2 - blood | Liraglutide - adverse effects | Incretins - adverse effects | Liraglutide - therapeutic use | Intention to Treat Analysis | Sex Factors | Venoms - therapeutic use | Incretins - therapeutic use | Liraglutide - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Gastrointestinal Diseases - chemically induced | Glucagon-Like Peptide-1 Receptor - agonists | Incretins - administration & dosage | Peptides - adverse effects | Peptides - therapeutic use | Patients | Original
Journal Article
Journal Article